Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,621 | Dovepress* | 9,226+ | 745 | 9,971 | |
| PubMed Central* | 395 | 140 | 535 | ||
| Totals | 9,621 | 885 | 10,506 | ||
| *Since 22 November 2018 | |||||
View citations on PubMed Central and Google Scholar